Session VI: New Modalities and Program Closing

Session Chair(s):

• David Michels, Genentech, a Member of the Roche Group
• Kathir Muthusamy, Regeneron Pharmaceuticals, Inc.

Session Speaker(s):

• Andrei Hutanu, F. Hoffmann - La Roche Ltd.
• Christopher Waite, Seagen Inc.
• Jennifer Hu, Bristol-Myers Squibb Company

Program Chair(s):

• Tara Enda, Bristol-Myers Squibb Company